Should insurance cover the cost of testing for and treating the BRCA gene mutation in all women?
Yes! Economies of scale will kick in, which will eventually drive down costs and save money on cancer treatment.
No! The cost of testing everyone outweighs the cost of cancer treatment for the few who test positive, which will lead to higher insurance premiums for all.
See this poll on: